Evaluation and Management of Pericarditis in Rheumatic Diseases

J Cardiovasc Pharmacol. 2024 Jun 1;83(6):491-502. doi: 10.1097/FJC.0000000000001494.

Abstract

This review summarizes the evaluation for underlying rheumatic conditions in patients presenting with acute pericarditis, treatment considerations for specific rheumatic conditions, and the role of imaging in diagnosis and monitoring. Pericarditis may be one of the initial presentations of a rheumatic disease or identified in a patient with known rheumatic disease. There is also growing evidence for using anti-inflammatory and immunosuppressive agents for treating recurrent pericarditis, which can overlap with the treatment of rheumatic diseases.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Pericarditis* / diagnosis
  • Pericarditis* / drug therapy
  • Pericarditis* / physiopathology
  • Pericarditis* / therapy
  • Predictive Value of Tests
  • Rheumatic Diseases / diagnosis
  • Rheumatic Diseases / drug therapy
  • Rheumatic Diseases / therapy
  • Rheumatic Heart Disease / diagnosis
  • Rheumatic Heart Disease / physiopathology
  • Rheumatic Heart Disease / therapy
  • Risk Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Anti-Inflammatory Agents